Biography
Dr. Anne Tsao is a medical oncologist at MD Anderson Cancer Center who specializes in the treatment of mesothelioma and other thoracic malignancies. She leads multiple clinical trials investigating immunotherapy and targeted therapy for mesothelioma and has published extensively on novel treatment approaches. Dr. Tsao is recognized as a leading expert in mesothelioma medical oncology.
Education & Training
- Medical Degree — Johns Hopkins University School of Medicine (Medicine)
- Residency — Johns Hopkins Hospital (Internal Medicine)
- Fellowship — Johns Hopkins Oncology Center (Medical Oncology)
Specialties & Procedures
Clinical Specialties
- Medical Oncology
- Thoracic Oncology
As a medical oncologist, Dr. Anne Tsao focuses on non-surgical treatment modalities including chemotherapy, immunotherapy, targeted therapy, and clinical trials.
Board Certifications
- American Board of Internal Medicine — Medical Oncology
- American Board of Internal Medicine — Internal Medicine
Research Focus
Novel therapeutic approaches for mesothelioma including immunotherapy combinations, biomarker-driven treatment selection, and clinical trial design for rare thoracic cancers.
Notable Publications
- Immunotherapy in malignant pleural mesothelioma. The Lancet Oncology, 2023.
Treatment Center
Dr. Anne Tsao practices at MD Anderson Cancer Center in Houston, TX.
Legal Resources for Mesothelioma Patients
Patients diagnosed with mesothelioma after asbestos exposure may be eligible for compensation through asbestos trust funds and legal claims. Over $30 billion remains available in trust funds nationwide.
Frequently Asked Questions
What does Dr. Tsao specialize in?
Dr. Tsao specializes in the medical (non-surgical) treatment of mesothelioma, including chemotherapy, immunotherapy, and clinical trials for novel treatments.